2022
- Andersen JD, Fabrin K, Petersen A, Zacho HD. 18F-FDG PET/CT in a Case of Urothelial Carcinoma in the Urachus Presenting as Colon Cancer. Diagnostics. 2022;12(1):31. doi: 10.3390/diagnostics12010031
- Danielsen MB, Jødal L, Riis J, Karmisholt JS, Valdórsson Ó, Jørgensen MG et al. Absorption rate of subcutaneously infused fluid in ill multimorbid older patients. PLOS ONE. 2022 okt.;17(10):e0275783. e0275783. doi: 10.1371/journal.pone.0275783
- Tram L, Kubik M, Kvist Jensen K, Almasi CE. Brown tumor mimicking metastases-the late manifestation of hyperparathyroidism. Acta Radiologica Open. 2022 sep.;11(9):1-3. doi: 10.1177/20584601221128415
- Alberts I, Mingels C, Zacho HD, Lanz S, Schöder H, Rominger A et al. Comparing the clinical performance and cost efficacy of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 in the diagnosis of recurrent prostate cancer: a Markov chain decision analysis. European Journal of Nuclear Medicine and Molecular Imaging. 2022 okt.;49(12):4252–4261. Epub 2021 nov. 13. doi: 10.1007/s00259-021-05620-9
- Bebbington N, Zacho HD, Holdgaard PC. Dose Savings Associated with Personalised CT Scan Range in F-18 Sodium-Fluoride PET-CT. European Journal of Nuclear Medicine and Molecular Imaging. 2022 sep. 22;49(Suppl. 1):S347.
- Jødal L, Brignone JI, Ladefoged PC, Lund L, Andersen TB. GFR determination in pigs based on late samples only. European Journal of Nuclear Medicine and Molecular Imaging. 2022 sep. 22;49(Suppl. 1):S451.
- Gossili F, Carlé A, Andersen TB, Zacho HD. Giant Parathyroid Tumor: Parathyroid Adenoma versus Parathyroid Carcinoma. Case reports in endocrinology. 2022 okt. 26;2022:7712097. doi: 10.1155/2022/7712097
- Lange MB, Petersen LJ, Lausen M, Bruun NH, Nielsen MB, Zacho HD. Influence of Prior Imaging Information on Diagnostic Accuracy for Focal Skeletal Processes-A Retrospective Analysis of the Consistency between Biopsy-Verified Imaging Diagnoses. Diagnostics. 2022 jul. 17;12(7):1735. doi: 10.3390/diagnostics12071735
- Beykan S, Tran-Gia J, Borup Jensen S, Lassmann M. Is a single late SPECT/CT based kidney 177Lu-dosimetry superior to hybrid dosimetry with sequential multiple time-point whole-body planar scans in combination with an early SPECT/CT? Physica Medica. 2022 aug.;100:39-50. Epub 2022 jun. 17. doi: 10.1016/j.ejmp.2022.06.002
- Jensen SB, Meyer LS, Nielsen NS, Nielsen SS. Issues with the European Pharmacopoeia Quality Control Method for 99mTc-Labelled Macroaggregated Albumin. Molecules. 2022 jul.;27(13):3997. doi: 10.3390/molecules27133997
- Bebbington NA, Zacho HD, Holdgaard PC. Lesion detection in 18F-sodium fluoride bone imaging: a comparison of attenuation-corrected versus nonattenuation-corrected PET reconstructions from modern PET-CT systems. Nuclear Medicine Communications. 2022 jan. 1;43(1):78-85. doi: 10.1097/MNM.0000000000001487
- Afzelius P, Morsing MK, Nielsen OL, Alstrup AKO, Jensen SB, Jødal L. Lymph Nodes Draining Infections Investigated by PET and Immunohistochemistry in a Juvenile Porcine Model. Molecules. 2022 apr. 27;27(9):2792. doi: 10.3390/molecules27092792
- Jakobsen SS, Frøkjær JB, Fisker RV, Kristensen SR, Thorlacius-Ussing O, Larsen AC. Monocyte recruitment in venous pulmonary embolism at time of cancer diagnosis in upper GI cancer patients. Thrombosis Research. 2022 maj;213(Suppl. 2):S11-S12. doi: 10.1016/S0049-3848(22)00190-6
- Bentestuen M, Al-Oybadi N, Zacho HD. Non-malignant FAPI-avid PET/CT Findings: A Review. European Journal of Nuclear Medicine and Molecular Imaging. 2022 sep. 22;49(Suppl. 1):S525.
- Zacho HD, Ravn S, Ejlersen JA, Fledelius J, Dolliner P, Nygaard ST et al. Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer. Nuclear Medicine Communications. 2022 jun.;43(6):680-686. Epub 2022 apr. 1. doi: 10.1097/MNM.0000000000001550
- Bentestuen M, Gossili F, Almasi CE, Zacho HD. Prevalence and significance of incidental findings on 68 Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET/CT: a systematic review of the literature. Cancer Imaging. 2022 sep. 3;22(1):44. doi: 10.1186/s40644-022-00484-0
- Zacho HD, Nalliah S, Petersen A, Petersen LJ. The clinical consequences of routine 68Ga-PSMA-11 PET/CT in patients with newly diagnosed prostate cancer, ISUP grade 5 and no metastases based on standard imaging - preliminary results. Scandinavian Journal of Urology. 2022;56(5-6):353-358. Epub 2022 sep. 8. doi: 10.1080/21681805.2022.2119272
- Aleksyniene R, Iyer V, Bertelsen HC, Nilsson MF, Khalid V, Schønheyder HC et al. The Role of Nuclear Medicine Imaging with 18F-FDG PET/CT, Combined 111In-WBC/99mTc-Nanocoll, and 99mTc-HDP SPECT/CT in the Evaluation of Patients with Chronic Problems after TKA or THA in a Prospective Study. Diagnostics. 2022 mar. 10;12(3):681. doi: 10.3390/diagnostics12030681
- Nalliah S, Zacho HD. The value of 68Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging. Nuclear Medicine Communications. 2022 okt. 1;43(10):1092-1098. Epub 2022 aug. 5. doi: 10.1097/MNM.0000000000001602
- Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients: a nationwide cohort study. BMJ Open. 2022 jun. 15;12(6):e058898. doi: 10.1136/bmjopen-2021-058898
- Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF-PET in the Staging of Skeletal Metastases of Newly Diagnosed, High-Risk Prostate Cancer Patients - a Nationwide Cohort Study. European Journal of Nuclear Medicine and Molecular Imaging. 2022;49(Suppl. 1):S402. EPS-231.
- Mogensen AW, Petersen LJ, Torp-Pedersen C, Nørgaard M, Pank MT, Zacho HD. Use of 18F-NaF PET in the staging of skeletal metastases of newly diagnosed, high-risk prostate cancer patients - a nationwide cohort study. European Urology. 2022;81(Suppl. 1):S1224. A0827 . doi: 10.1016/S0302-2838(22)00904-6
Ovenstående rapport er sorteret efter: Titel